Area of research
Pulmonary and Respiratory Medicine · Pediatrics, Perinatology and Child Health
Research interest
Research interests include Neonatal Respiratory Health Research, Respiratory Support and Mechanisms, Neuroscience of respiration and sleep, and Neonatal and fetal brain pathology.
Moving on from clinical animal-derived surfactants to peptide-based synthetic pulmonary surfactant.
Structure and Function of Canine SP-C Mimic Proteins in Synthetic Surfactant Lipid Dispersions.
Vascular and pulmonary effects of ibuprofen on neonatal lung development
Evaluation of a Novel Dry Powder Surfactant Aerosol Delivery System for Use in Premature Infants Supported with Bubble CPAP.
Lung Surfactant Protein B Peptide Mimics Interact with the Human ACE2 Receptor.
Emulation of the structure of the Saposin protein fold by a lung surfactant peptide construct of surfactant Protein B.
Synthetic Lung Surfactant Treatment for COVID-19 Pneumonia
Advances in synthetic lung surfactant protein technology.
Aerosol delivery of dry powder synthetic lung surfactant to surfactant-deficient rabbits and preterm lambs on non-invasive respiratory support
Aerosol delivery of dry powder synthetic lung surfactant to surfactant-deficient rabbits and preterm lambs on non-invasive respiratory support
Bone Morphogenetic Protein 9 Protects against Neonatal Hyperoxia-Induced Impairment of Alveolarization and Pulmonary Inflammation
Metformin attenuates hyperoxia-induced lung injury in neonatal rats by reducing the inflammatory response
Deficiency or inhibition of lysophosphatidic acid receptor 1 protects against hyperoxia-induced lung injury in neonatal rats
Angiotensin II type 2 receptor ligand PD123319 attenuates hyperoxia-induced lung and heart injury at a low dose in newborn rats
Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury